back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-02-19 16:30 Tx date 2026-02-01 |
$BCT
BriaCell Therapeutics Corp. |
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,700
+30,000 vol $5.59 each |
30,769 | |
| Filed 2026-02-19 16:27 Tx date 2026-02-01 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$296,270
+53,000 vol $5.59 each |
57,000 | |
| Filed 2026-02-19 16:23 Tx date 2026-02-01 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$296,270
+53,000 vol $5.59 each |
55,427 | |
| Filed 2026-02-19 16:18 Tx date 2026-02-01 |
$BCT
BriaCell Therapeutics Corp. |
LOPEZ-LAGO, MIGUEL
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,700
+30,000 vol $5.59 each |
30,167 | |
| Filed 2026-02-19 16:17 Tx date 2026-02-01 |
$BCT
BriaCell Therapeutics Corp. |
LOPEZ-LAGO, MIGUEL
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$167,700
+30,000 vol $5.59 each |
||
| Filed 2026-02-19 16:15 Tx date 2026-02-01 |
$BCT
BriaCell Therapeutics Corp. |
DEL PRIORE, GIUSEPPE
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$210,743
+37,700 vol $5.59 each |
38,767 | |
| Filed 2026-02-19 16:07 Tx date 2026-02-01 |
$BCT
BriaCell Therapeutics Corp. |
LOPEZ-LAGO, MIGUEL
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$167,700
+30,000 vol $5.59 each |
||
| Filed 2025-11-27 09:27 Tx date 2021-08-03 |
$BCT
BriaCell Therapeutics Corp. |
Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,480,000 | ||
| Filed 2021-08-12 09:25 Tx date 2021-08-03 |
$BCT
BriaCell Therapeutics Corp. |
Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-26 20:51 Tx date 2022-02-25 |
$BCT
BriaCell Therapeutics Corp. |
Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,945
+3,887 vol $7.70 each |
1,643,887 | |
| Filed 2025-11-26 20:50 Tx date 2024-11-28 |
$BCT
BriaCell Therapeutics Corp. |
Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,203
+1,000 vol $1.20 each |
1,644,887 | |
| Filed 2025-10-02 16:21 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+5,000 vol |
5,000 | |
| Filed 2025-10-02 16:20 Tx date 2023-06-20 |
$BCT
BriaCell Therapeutics Corp. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 16:18 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+15,000 vol |
15,000 | |
| Filed 2025-10-02 16:16 Tx date 2020-12-01 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 16:14 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Taub, Rebecca Anne
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+5,000 vol |
5,000 | |
| Filed 2025-10-02 16:12 Tx date 2019-03-07 |
$BCT
BriaCell Therapeutics Corp. |
Taub, Rebecca Anne
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 16:10 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+100,000 vol |
100,000 | |
| Filed 2025-10-02 16:08 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 16:03 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+15,000 vol |
15,000 |